NFKB1 and liver cancer: NF-κB inhibition through anti-TNF treatment resulted in apoptosis of transformed hepatocytes and failure to progress to HCC, indicating that TNF-induced NF-κB activation is essential for promoting inflammation-associated liver cancer [84].